文献速递糖尿病骨质疏松与钙磷/甲状旁腺

血清25-羟基维生素D浓度、糖尿病、遗传易感性与新发慢性肾脏病的关系

Relationships of Serum 25-Hydroxyvitamin D Concentrations, Diabetes, Genetic Susceptibility, and New-Onset Chronic Kidney Disease.
PubMed 文献 · Diabetes Care · 2022-01-01

基于英国生物银行348,243名基线无慢性肾脏病(CKD)的成人,中位随访12.1年记录9,344例新发CKD。在糖尿病患者中,基线血清25-羟基维生素D(25OHD)每升高1个标准差,新发CKD风险显著降低(校正HR 0.91,95%CI 0.86-0.96);非糖尿病患者中无显著关联(校正HR 0.98,95%CI 0.96-1.01;交互作用P=0.004)。

要点

  • 糖尿病患者中基线血清25OHD每升高1个标准差,新发CKD风险校正HR 0.91(95%CI 0.86-0.96)。
  • 非糖尿病患者中血清25OHD与新发CKD无显著关联(校正HR 0.98,95%CI 0.96-1.01)。
  • 糖尿病患者中,25OHD≥50 nmol/L者较<25 nmol/L者新发CKD风险校正HR 0.77(95%CI 0.67-0.89)。

核心结论

  • 在糖尿病患者中,基线血清25OHD与新发CKD呈显著负相关;在非糖尿病患者中未发现此负相关。

研究设计与样本

  • 前瞻性队列研究,纳入英国生物银行348,243名基线无CKD的成人,血清25OHD采用化学发光免疫分析法测定,CKD遗传风险评分基于263个与估算肾小球滤过率显著相关的单核苷酸多态性计算,主要结局为新发CKD。

主要发现

  • 中位随访12.1年,共记录9,344例新发CKD。
  • 糖尿病患者中,基线血清25OHD每升高1个标准差,新发CKD的校正HR为0.91(95%CI 0.86-0.96);非糖尿病患者中校正HR为0.98(95%CI 0.96-1.01);血清25OHD与糖尿病的交互作用P=0.004。
  • 糖尿病患者中,与基线血清25OHD<25 nmol/L者相比,25OHD≥50 nmol/L者新发CKD风险显著降低(校正HR 0.77,95%CI 0.67-0.89)。
  • 糖尿病患者中,CKD遗传风险未显著改变基线血清25OHD与新发CKD之间的关联(交互作用P=0.127)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The prospective relation of vitamin D status with the risk of chronic kidney diseases (CKD) remains uncertain. We aimed to examine the association of serum 25-hydroxyvitamin D (25OHD) with new-onset CKD in participants with and without diabetes at baseline and examine the potential modifications by genetic susceptibility on the association. RESEARCH DESIGN AND METHODS: Included were 348,243 adults from the UK Biobank without prior CKD at baseline. Serum 25OHD concentrations were measured by chemiluminescent immunoassay method. Genetic risk score of CKD was calculated by 263 single nucleotide polymorphisms, which showed significant associations with estimated glomerular filtration rate. The primary outcome was new-onset CKD. RESULTS: During a median follow-up duration of 12.1 years, 9,344 new-onset CKD were documented. Overall, there was a significant inverse association between baseline serum 25OHD and new-onset CKD in participants with diabetes (per SD increment, adjusted hazard ratio [HR] 0.91; 95% CI 0.86-0.96), but not in those without diabetes (per SD increment, adjusted HR 0.98; 95% CI 0.96-1.01; P-interaction between serum 25OHD and diabetes = 0.004). Accordingly, among participants with diabetes, compared with those baseline serum 25OHD <25 nmol/L, a significantly lower risk of new-onset CKD was found in those with 25OHD ≥50 nmol/L (adjusted HR 0.77; 95% CI 0.67-0.89). Moreover, the genetic risk of CKD did not significantly modify the association between baseline serum 25OHD and new-onset CKD among participants with diabetes (P-interaction = 0.127). CONCLUSIONS: There was an inverse association between baseline serum 25OHD and new-onset CKD in participants with diabetes. The inverse association was not found in participants without diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zhou C, He P, Ye Z, et al. Relationships of Serum 25-Hydroxyvitamin D Concentrations, Diabetes, Genetic Susceptibility, and New-Onset Chronic Kidney Disease. Diabetes Care. 2022. PMID: 36102808. doi:10.2337/dc22-1194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。